what's new in the management of hormone naïve & castrate resistant prostate cancer webcast (2021)
Published 2 years ago • 541 plays • Length 1:53:11Download video MP4
Download video MP3
Similar videos
-
1:30:52
what's new in the management of hormone naïve & castrate resistant prostate cancer
-
1:52:45
aua guidelines on advanced/metastatic/castration resistant prostate cancer webcast (2021)
-
25:31
management of advanced hormone-sensitive and castration-resistant prostate cancer
-
39:15
aua: sequencing of agents and combination therapy in castrate resistant prostate cancer
-
7:07
treatment landscape of castrate-resistant prostate cancer
-
4:15
top 2 vitamin supplements to avoid with prostate cancer | vitamins and prostate cancer
-
3:25
life expectancy with prostate cancer diagnosis
-
3:07
hormone agents and prostate cancer
-
1:01:45
metastatic hormone sensitive prostate cancer: expert guidance for urologists
-
11:51
expert video report on castration sensitive and resistant prostate cancer - 2021 asco annual meeting
-
5:45
understanding your options if hormone therapy stops working
-
3:56
about metastatic castrate-resistant prostate cancer
-
1:15
updates in the treatment of castration-resistant prostate cancer
-
2:03:45
aua2019 048ic: novel agents & concepts in the management of hormone naïve & crpc
-
15:49
adt resistant non-metastatic prostate cancer (nmcrpc) - 2021 prostate cancer patient conference
-
42:05
androgens, hormonal therapy & response in prostate cancer - summit 2021
-
27:12
myth busted: current studies of prostate cancer hormone resistance (boris alekseev)
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
-
42:08
prostate cancer: clinical guidelines, novel therapies, and therapeutic uncertainty
-
7:46
treating non-metastatic castrate resistant prostate cancer | ask a prostate expert, mark scholz, md
-
30:30
exploring the evolution in metastatic hormone sensitive & castration resistant prostate cancer
-
7:04
are you aware of castration-resistant prostate cancer?